Lung Endothelial MicroRNA-1 Regulates Tumor Growth and Angiogenesis.

Area of Science:

• Oncology
• Molecular Biology
• Vascular Biology

Background:

• Endothelial cells are crucial for tumor progression and angiogenesis.
• Vascular endothelial growth factor (VEGF) down-regulates microRNA-1 (miR-1) in lung endothelium.
• The role of miR-1 in non-small cell lung cancer (NSCLC) endothelium requires further investigation.

Purpose of the Study:

• To investigate the clinical significance of miR-1 in NSCLC.
• To determine the specific role of miR-1 in tumor endothelium.
• To explore miR-1's therapeutic potential in NSCLC.

Main Methods:

• miR-1 levels were quantified using Taqman assays.
• Endothelial cells were isolated via magnetic sorting.
• Vascular-specific miR-1 lentiviral vectors and inducible transgenic mice were utilized.
• Experiments involved KRAS^{G12D mut}/Trp^53-/- (KP) mice, VEGF transgenic mice, Lewis lung carcinoma xenografts, and primary endothelial cells.

Main Results:

• Lower miR-1 levels were observed in NSCLC tumors compared to adjacent normal tissue and in endothelial cells from NSCLC tumors.
• Tumor miR-1 levels correlated with overall patient survival.
• Overexpression of miR-1 in endothelial cells reduced tumor burden, xenograft growth, vascularity, and angiogenesis.
• miR-1 regulates endothelial cell proliferation, DNA synthesis, and ERK1/2 activation, targeting the myeloproliferative leukemia oncogene.

Conclusions:

• Endothelial miR-1 is significantly down-regulated in NSCLC.
• miR-1 acts as a critical regulator of tumor progression and angiogenesis in the lung endothelium.
• Restoring endothelial miR-1 presents a potential therapeutic strategy for NSCLC.